AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Clinical trial NCT00547651 · COMPLETED

Trial details

NCT number: NCT00547651
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2007-09-01
Primary completion: 2011-05-01
Enrollment: 637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.